Independent compliance review service. Not affiliated with, or endorsed by, the Therapeutic Goods Administration.

Compliance guide

TGA Compliance Priorities 2026–27: What Changed

Updated 4 July 2026 · 6 min read · Section 42 Compliance

Quick answer — What are the TGA's 2026–27 compliance priorities?

Five overarching principles and 12 priority product focus areas — with medicinal cannabis among them, alongside weight-loss medicines, cosmetic-procedure products and vapes. The structural changes matter most: focus areas are now reviewed quarterly instead of annually, surveillance of websites and social media is proactive rather than complaint-driven, influencer endorsements and AI-generated content are explicitly targeted, and the TGA has committed to faster, more publicly visible enforcement.

From complaint-driven to surveillance-driven

The operational shift is the important one. Businesses that assumed enforcement began with a complaint now face a regulator that scans digital channels on its own initiative, coordinates with digital platforms to remove content at scale, and cross-references Ahpra prescribing data. Non-compliant marketing no longer needs an enemy or a disgruntled patient to be found — it needs only to be public.

Quarterly reviews mean the pressure doesn't plateau. The regulator has signalled it will keep adjusting focus in near real-time as new patterns emerge — the same cadence our monthly monitoring digests are built around.

The new content frontiers: AI and influencers

For the first time, AI-generated marketing content and influencer endorsements are named targets. That captures a lot of current practice: AI-written blog posts and social captions that drift into condition references, AI-generated imagery with botanical motifs, and paid creators whose 'personal journey' content functions as testimonial advertising. If a human marketer couldn't lawfully publish it, an AI tool doesn't launder it.

Visibility as a penalty multiplier

The TGA has committed to publicising enforcement more prominently. A notice that once resolved quietly now arrives with a media release naming your business — which is why clean audit reports increasingly matter beyond the regulator: insurers, investors, acquirers and clinical partners read the same announcements. In a sector already under commercial pressure — Australian medicinal cannabis sales fell sharply following the regulatory crackdown — a public enforcement announcement is a revenue event, not just a legal one.

Frequently asked questions

Is medicinal cannabis really a named focus area?

Yes — it is one of the 12 priority focus areas in the TGA's 2026–27 framework, effective from January 2026, with quarterly reviews thereafter.

Does AI-generated content get any special treatment?

Only negative — it's explicitly targeted. The advertising rules apply to the content regardless of how it was produced, and the 2026–27 framework calls out AI-generated claims specifically.

What should operators do first?

Baseline audit of website and socials, remediate by severity, then monitor monthly — the cadence that matches the regulator's own quarterly review rhythm.

Are other sectors affected the same way?

Yes — weight-loss medicines, cosmetic injectables and vapes face the same framework, which is why our engine and templates extend to other prescription-medicine marketing.

Check where you stand

The breach patterns in this guide are exactly what our audit engine checks. Start with the free 10-point self-assessment, a $149 rapid scan, or the $449 full audit. Everything is delivered by email.